Editorial: Plant metabolites in drug discovery: the prism perspective between plant phylogeny, chemical composition, and medicinal efficacy, volume III
Da-Cheng Hao,Yao-Xuan Wang,Richard W. Spjut,Chun-Nian He
DOI: https://doi.org/10.3389/fphar.2024.1530039
IF: 5.6
2024-12-14
Frontiers in Pharmacology
Abstract:There is a Chinese saying that goes, "The most profound takes the simpliest form". The phylogenetically close taxa usually have similar phytometabolite profiles, and taxa that are closely related in chemotaxonomy often have analogous ethnopharmacological uses and display similar bioactivities. This is the simple core idea of "Pharmacophylogeny", and consequent the proposed term "Pharmacophylomics" aims to disentangle the intricate relationships and connectivity between medicinal plant phylogeny, phytochemical constituents and bioactivities/therapeutic utilities based on emerging omics data (Fig. 1) (Hao and Xiao, 2023);, such as those of genomics, transcriptomics and metabolomics data are very useful, so as to promote pharmaceutical resource discovery and plantbased drug R&D. In recent years, more phytomedicine researchers become familiar with the theory and methods of pharmacophylogeny (Moutouama and Gaoue, 2024), but the research on the simultaneous examination of phylogeny/phylogenomics, phytochemical constituentsstry, and bioactivity is still limited. Based on the 21 papers published in Volume I and II of this Research Topic (Hao et al., 2023a), the volume III furtherhas contributed eight brilliant enlightening papers on the phylogenomics, metabolomics, network pharmacology, ethnopharmacology and bioactivity of various medicinal species, covering algae (Su et al., 2024), monocot (Bencheikh et al., 2024;Luo et al., 2024), basal eudicot (Bencheikh et al., 2024;Pan et al., 2024), core eudicot (Ding et al., 2024), Lamiids (Liu et al., 2024) and Campanulids (Luo et al., 2024), etc. These research findingworks provide rich phytometabolite and bioactivity information for deeper exploration on 设置了格式: 非突出显示 pharmacophylogeny, facilitating the analysis of distribution patterns of various medicinal compounds and pharmacological activities on the phylogenetic tree (Hao et al., 2024a), the inference of biosynthetic pathways and therapeutic mechanisms of phytometabolites, and the search for alternative/complementary medicine sources.Fermentation is an important concoction processing technique for botanical drugphytomedicines, which transforms and enhances the active ingredients of herbal medicine via specific microbial processes (Luo et al., 2024), therefore shifting their pharmacological effects. FermentationThis TCM processing method may contribute additional dimension for expanding theory and application of pharmacophylogeny, as similar fermentation strains and conditions could be used in species with similar phytometabolites, and overlapping but not completely consistent chemical profiles could be generated after microbial transformation, which provide more chemical space for the use of fermented botanical drugs in areas such as anti-cancer, hypolipidemic, antioxidant, antimicrobial, cosmetologycosmetics, and intestinalgut microflora regulation. The fermentation technology reduces toxic side effects of some crude drugs, enhances drug efficacy, and creates new active ingredients, which could be especially important to the species rich and alkaloid abundant genera (Pan et al., 2024).The puzzling interaction between microbial strains and crude drugs is another intriguing topic.Managing factors affecting the microbial activities and fermentation process is vital for the successful transformation and enhancement efficacy improvement of herbal drugs. In this regard, the pharmacophylogeny approach also has its place. For example, we can assume that bacteria or fungi with close genetic relationships interact with specific plant compounds in a similar way, and thus predict the similarities and differences in the spectrum of transformation products based on the composition of the microbial community. There is too much work to be done in this area, and it is not limited to TCM species. Fermentation microbial research can be conducted on ethnomedicine species around the world, e.g., those of Africa (Bencheikh et al., 2024) and Asia (Liu et al., 2024). The molecular phylogeny and metabolomic information are essential to understand the medicinal value of each microbial/plant genus and to develop alternative medicinal resources. They are also applicable in food medicine continuum (FMC) plants, which are extensively distributed in worldwide ethnomedicine. Pharmacophylogeny is very useful in expanding FMC and medicinal plant resources (Hao and Xiao, 2023), authentication/quality control of herbal medicines, predicting the chemicals or bioactive constituents of herbals and identification/quantification of chemicals. Reports on 设置了格式: 非突出显示 phytometabolites and pharmacological properties of algae (Su et al., 2024), regarded as lower plants, are relatively few, despite the presence of many types of vascular plant metabolites therein, e.g., coumarins and diterpenes. In the coming years, pharmacophylogeny and pharmacophylomics could be more powerful in mining natural products from -Abstract Truncated-
pharmacology & pharmacy